Literature DB >> 28263168

Red blood cell components: time to revisit the sources of variability.

Rosemary L Sparrow1.   

Abstract

Quality and safety of red blood cell (RBC) components is managed by screening of donors and strict regulatory controls of blood collection, processing and storage procedures. Despite these efforts, variations in RBC component quality exist as exemplified by the wide range in storage-induced haemolysis. This article provides a brief overview of the variables that contribute or potentially contribute to the quality of stored RBC components, including blood collection, processing, and donor-related variables. Particular focus is made on donor health and lifestyle factors that are not specifically screened and may impact on the physicobiochemical properties of RBCs and their storability. Inflammatory and oxidative stress states may be especially relevant as RBCs are susceptible to oxidative injury. Few studies have investigated the effect of specific donor-related variables on the quality of stored RBC components. Donor-related variables may be unaccounted confounders in the "age of blood" clinical studies that compared outcomes following transfusion of fresher or longer-stored RBC components. The conclusion is drawn that the blood donor is the greatest source of RBC component variability and the least "regulated" aspect of blood component production. It is proposed that more research is needed to better understand the connection between donor-related variables and quality consistency of stored RBC components. This could be very important given the impact of modern lifestyles that sees escalating rates of non-communicable health conditions that are associated with increased oxidative stress, such as hypertension, obesity and diabetes in children and adults, as well as an ageing population in many countries. The effect of these changes to global health and population demographics will impact on blood donor panels, and without significant new research, the consequences on the quality of stored blood components and transfusion outcomes are unknown.

Entities:  

Mesh:

Year:  2017        PMID: 28263168      PMCID: PMC5336332          DOI: 10.2450/2017.0326-16

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  99 in total

1.  Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials.

Authors:  Larry J Dumont; James P AuBuchon
Journal:  Transfusion       Date:  2008-02-22       Impact factor: 3.157

Review 2.  The impact of diet on asthma and allergic diseases.

Authors:  Valerie Julia; Laurence Macia; David Dombrowicz
Journal:  Nat Rev Immunol       Date:  2015-05       Impact factor: 53.106

Review 3.  The effect of holding times of whole blood and its components during processing on in vitro and in vivo quality.

Authors:  Pieter F van der Meer; Dirk de Korte
Journal:  Transfus Med Rev       Date:  2015-01

4.  The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response.

Authors:  Katherine Radwanski; Olivier Garraud; Fabrice Cognasse; Hind Hamzeh-Cognasse; Jean-Marc Payrat; Kyungyoon Min
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

5.  Effects of red-cell storage duration on patients undergoing cardiac surgery.

Authors:  Marie E Steiner; Paul M Ness; Susan F Assmann; Darrell J Triulzi; Steven R Sloan; Meghan Delaney; Suzanne Granger; Elliott Bennett-Guerrero; Morris A Blajchman; Vincent Scavo; Jeffrey L Carson; Jerrold H Levy; Glenn Whitman; Pamela D'Andrea; Shelley Pulkrabek; Thomas L Ortel; Larissa Bornikova; Thomas Raife; Kathleen E Puca; Richard M Kaufman; Gregory A Nuttall; Pampee P Young; Samuel Youssef; Richard Engelman; Philip E Greilich; Ronald Miles; Cassandra D Josephson; Arthur Bracey; Rhonda Cooke; Jeffrey McCullough; Robert Hunsaker; Lynne Uhl; Janice G McFarland; Yara Park; Melissa M Cushing; Charles T Klodell; Ravindra Karanam; Pamela R Roberts; Cornelius Dyke; Eldad A Hod; Christopher P Stowell
Journal:  N Engl J Med       Date:  2015-04-09       Impact factor: 91.245

6.  Red Blood Cell Dysfunction Induced by High-Fat Diet: Potential Implications for Obesity-Related Atherosclerosis.

Authors:  Dusten Unruh; Ramprasad Srinivasan; Tyler Benson; Stephen Haigh; Danielle Coyle; Neil Batra; Ryan Keil; Robert Sturm; Victor Blanco; Mary Palascak; Robert S Franco; Wilson Tong; Tapan Chatterjee; David Y Hui; W Sean Davidson; Bruce J Aronow; Theodosia Kalfa; David Manka; Abigail Peairs; Andra Blomkalns; David J Fulton; Julia E Brittain; Neal L Weintraub; Vladimir Y Bogdanov
Journal:  Circulation       Date:  2015-10-14       Impact factor: 29.690

Review 7.  The role of red blood cell deformability and Na,K-ATPase function in selected risk factors of cardiovascular diseases in humans: focus on hypertension, diabetes mellitus and hypercholesterolemia.

Authors:  J Radosinska; N Vrbjar
Journal:  Physiol Res       Date:  2016-09-19       Impact factor: 1.881

8.  The heritability of hemolysis in stored human red blood cells.

Authors:  Thomas J Van 't Erve; Brett A Wagner; Sean M Martin; C Michael Knudson; Robyn Blendowski; Mignon Keaton; Tracy Holt; John R Hess; Garry R Buettner; Kelli K Ryckman; Benjamin W Darbro; Jeffrey C Murray; Thomas J Raife
Journal:  Transfusion       Date:  2015-02-02       Impact factor: 3.157

9.  Self-report of fruit and vegetable intake that meets the 5 a day recommendation is associated with reduced levels of oxidative stress biomarkers and increased levels of antioxidant defense in premenopausal women.

Authors:  Stephanie M Rink; Pauline Mendola; Sunni L Mumford; Jill K Poudrier; Richard W Browne; Jean Wactawski-Wende; Neil J Perkins; Enrique F Schisterman
Journal:  J Acad Nutr Diet       Date:  2013-03-19       Impact factor: 4.910

Review 10.  World distribution, population genetics, and health burden of the hemoglobinopathies.

Authors:  Thomas N Williams; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

View more
  7 in total

1.  Assessing quality of blood components derived from whole blood treated with riboflavin and ultraviolet light and separated with a fully automated device.

Authors:  Michał Bubiński; Agnieszka Gronowska; Paweł Szykuła; Agnieszka Woźniak; Aleksandra Rodacka; Scott Santi; Marcia Cardoso; Elżbieta Lachert
Journal:  Blood Transfus       Date:  2022-02-01       Impact factor: 5.752

2.  Hemolysis Pathways during Storage of Erythrocytes and Inter-Donor Variability in Erythrocyte Morphology.

Authors:  Kathryn A Melzak; John L Spouge; Clemens Boecker; Frank Kirschhöfer; Gerald Brenner-Weiss; Karen Bieback
Journal:  Transfus Med Hemother       Date:  2020-07-16       Impact factor: 3.747

Review 3.  Heterogeneity of Red Blood Cells: Causes and Consequences.

Authors:  Anna Bogdanova; Lars Kaestner; Greta Simionato; Amittha Wickrema; Asya Makhro
Journal:  Front Physiol       Date:  2020-05-07       Impact factor: 4.566

4.  Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality - a pooled patient data analysis of 16 observational trials.

Authors:  Monica S Y Ng; Michael David; Rutger A Middelburg; Angela S Y Ng; Jacky Y Suen; John-Paul Tung; John F Fraser
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

5.  The effect of perturbations of the glycocalyx on microvascular perfusion in the obese trauma population: an in vitro study.

Authors:  Lawrence N Diebel; Alexander Liviu Marinica; David Edelman; David Liberati
Journal:  Trauma Surg Acute Care Open       Date:  2021-04-26

6.  Evaluation of quality matrix when practice changed from triple bags to quadruple (top and bottom) bags: In vitro analysis of blood components!

Authors:  Gunjan Bhardwaj; Aseem Kumar Tiwari; Geet Aggarwal; Swati Pabbi; Jyoti Sharma; Aanchal Luthra; Anand Upadhyay
Journal:  Asian J Transfus Sci       Date:  2021-06-12

7. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-08       Impact factor: 1.595

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.